Cost estimation of point of care b-type natriuretic peptide for the diagnosis of heart failure in the emergency department:application to Alberta
Chuck A, Jacobs P
Record ID 32005000437
English
Authors' recommendations:
The aim of this report is to provide a cost estimate, over a one year time period from a payer's perspective, of Biosite Triage Point-of-Care (POC) B-Type Natriuretic Peptide (BNP) assay used to rule out congestive heart failure (CHF) from other pulmonary conditions for patients presenting in Alberta emergency departments with acute dyspnea, but who do not have acute mycardial infarction (AMI), renal dysfunction (RD), or unstable angina (UA). The scope of this report is limited to the use of BNP for diagnosis and does not address prognosis, management, or patient monitoring.
Details
Project Status:
Completed
Year Published:
2005
URL for published report:
http://www.ihe.ca/advanced-search/cost-estimation-of-point-of-care-b-type-natriuretic-peptide-for-the-diagnosis-of-heart-failure-in-the-emergency-department-application-to-alberta
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Canada
- Costs and Cost Analysis
- Emergency Service, Hospital
- Point-of-Care Systems
- Predictive Value of Tests
- Sensitivity and Specificity
- Atrial Natriuretic Factor
- Heart Failure
- Natriuretic Peptide, Brain
Contact
Organisation Name:
Institute of Health Economics
Contact Address:
1200, 10405 Jasper Avenue, Edmonton, Alberta, Canada, T5J 3N4. Tel: +1 780 448 4881; Fax: +1 780 448 0018;
Contact Name:
djuzwishin@ihe.ca
Contact Email:
djuzwishin@ihe.ca
Copyright:
<p>Alberta Heritage Foundation for Medical Research (AHFMR)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.